Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001669866-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 17, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
130,584
Total Value
$499,974.96
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 59,700 | $6.70 | $399,990.00 | 59,700 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 5,592 | $17.88 | $99,984.96 | 65,292 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 59,700 | $0.00 | $0.00 | 41 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 5,592 | $0.00 | $0.00 | 269,408 | Direct | โ | View Details |